Learn

Arthrosamid side effects: what the studies report

Every medical treatment has side effects, and honest information beats reassurance. Here is what the published evidence reports for Arthrosamid: what is common and temporary, what is rare, and what is done to reduce the risks.

Common and temporary

The most common post-treatment effects are temporary joint discomfort and a sensation of swelling in the treated knee. These symptoms are typically mild and resolve within days to weeks as the gel settles and integrates. They are expected effects of an intra-articular injection, not complications.

Source: Bliddal 2021, J Orthop Res Ther; Overgaard 2019.

What the clinical studies found

Across clinical studies of the treatment, no serious treatment-related adverse events were reported. The product has been in routine European use since its CE marking, with thousands of patients treated across more than 220 clinics, and was approved by Health Canada in 2024.

Source: Bliddal 2021, J Orthop Res Ther; Overgaard 2019. Manufacturer data on file. Regulatory status as of 2026 (Health Canada approved 2024; CE marked; not FDA approved).

Rare risks, and how they are reduced

As with any injection into a joint, rare risks include joint infection, bleeding, and allergic reaction. To help minimise them, every procedure at our clinic is performed under ultrasound guidance with strict sterile technique, and a prophylactic oral antibiotic is taken 1 to 2 hours before the injection as part of the Restoration Medical protocol. During your consultation, Dr. Nguyen reviews the potential benefits and risks with you so you can make an informed decision.

Source: Contura microbiology statement, 2021. IFU and consent form.

Not for everyone

Some people should not have this treatment, including anyone with a prior knee replacement, an active infection at the injection site, or a previous non-absorbable injectable in the knee. The full list is on the candidacy page, and eligibility is always confirmed by a physician in person before treatment.

Common questions

Is Arthrosamid safe?

In clinical studies, no serious treatment-related adverse events were reported. The product is a Class III medical device approved by Health Canada (2024) and CE marked in Europe, where it has been used in routine practice across more than 220 clinics. As with any injection, rare risks exist, and a physician reviews them with you before treatment.

What is the most common side effect?

Temporary joint discomfort and a sensation of swelling after the injection. These symptoms are typically mild and resolve within days to weeks.

How is the infection risk managed?

Joint infection is rare but taken seriously. Every procedure is performed with strict sterile technique under ultrasound guidance, and patients take a prophylactic oral antibiotic 1 to 2 hours before the injection as part of the Restoration Medical protocol.

Who should not have Arthrosamid?

It is not suitable for people with a prior knee replacement or other foreign material in the knee, recent knee arthroscopy, an active infection or skin disease at the injection site, haemophilia or uncontrolled anticoagulation, or a previous non-absorbable injectable product in the knee. See the candidacy page for the full list.

There is no cure for osteoarthritis. Treatment may reduce or relieve knee pain, but symptoms may not improve and in some cases may worsen. Individual results vary.

Book a consultation

Take the next step

A consultation reviews your diagnosis, confirms whether the treatment is suitable for you, and answers your questions. The consultation fee is included in the all-inclusive treatment price.

  • Health Canada approved (2024)
  • Physician-led care
  • Consultation fee included
  • 25 minutes from Toronto Pearson
Book a consultation